Clinical Trial Update: An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)

View source ↗

Summary

An observational study funded by Hoffmann-La Roche evaluates patients' perceptions of treatment with erythropoiesis-stimulating agents in chronic kidney disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• erythropoiesis-stimulating agents

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED